Blog

Andrea Necchi: MRI should be a routine for daily management of MIBC

Collage photo of Andrea Necchi and Nick James

Sep 1, 2024, 20:21

Andrea Necchi: MRI should be a routine for daily management of MIBC

Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared Nick James‘s, Professor of Prostate and Bladder Cancer Research at The Institute of Cancer Research, post on X, adding:

“MRI should be a routine for daily management of MIBC. cCR definition and modern bladder-sparing strategies will rely on it. Congratulations a step forward to this direction.”

Quoting Nick James’s post:

“Out today, the full report on BladderPath – MRI directed staging for newly diagnosed bladder cancer vs TURBT. Early use of MRI halves time to treatment for MIBC. Time to rethink the staging pathway.”

Source: Andrea Necchi/X and Nick James/X

Andrea Necchi bladder cancer BladderPath cancer ICR JCO Journal of Clinical Oncology MIBC MRI OncoDaily Oncology prostate cancer The Institute of Cancer Research

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage